arrow
M

Marika Guercio

bambino gesu childrens hospital
H指数:24
被引数:3,546

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Furuncular myiasis by Cordylobia anthropophaga in three Italian children: First case series and implications for non-endemic regions

牛蛆蝇属幼虫引起的疖肿性蝇蛆病在三个意大利儿童中的病例:首个病例系列及对非流行地区的启示

2026-05-010
OA
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial

GD2靶向CAR T细胞在高风险神经母细胞瘤中的应用:一项I/II期临床试验。Nat. Med

2025-08-210
PRE
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells

肿瘤衍生的g-csf在骨肉瘤模型中诱导免疫抑制微环境,降低对CAR.GD2 T细胞的反应

2024-12-180
OAAI
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study

mRNA SARS-CoV-2疫苗治疗儿童癌症后的体液和细胞免疫反应: 一项初步观察研究

HELIYON
IF3.6
2024-07-011
OAAI
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
2024-03-298
OAAI
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies
2023-06-0921
OAAI
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters
2023-05-256
OAAI
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma

复发或难治性高危神经母细胞瘤的GD2-CART01

2023-04-06200
PRE
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia

基于CAR.CD123-NK细胞的安全有效的现成免疫疗法治疗急性髓系白血病

2022-11-0544
OAAI
SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best
2021-10-2069
OAAI
Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies

CAR构建体中包含可诱导的半胱天冬酶9自杀基因可增加b细胞恶性肿瘤中CAR.CD19 T细胞疗法的安全性

2021-10-1937
OAAI
Strategy to prevent epitope masking in CAR.CD19+B-cell leukemia blasts
2021-06-1610
OAAI
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group (vol 10, 489, 2020)
2020-06-232
OAAI
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T cells
2020-05-0749
OAAI
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
2020-04-1546
OAAI
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
LEUKEMIA
IF13.4
2019-11-1970
OAAI